WCN26-6228 Real-World Assessment of Nefecon as First-Line Therapy in IgA Nephropathy: Efficacy and Safety Outcomes
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Kidney International Reports
- Volume
- 11
- Issue
- 4
- Pages
- 104848–104848
- Publication date
- 25 March 2026
- Language
- EN